| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.23 | 1e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.049 | 0.3 |